Abstract:Antigen-presenting cells (APCs) are pivotal mediators of immune responses. Their role has increasingly been spotlighted in the realm of cancer immunology, particularly as our understanding of immunotherapy continues to evolve and improve. There is growing evidence that these cells play a non-trivial role in cancer immunity and have roles dependent on surface markers, growth factors, transcription factors, and their surrounding environment. The main dendritic cell (DC) subsets found in cancer are conventional DCs (cDC1 and cDC2), monocyte-derived DCs (moDC), plasmacytoid DCs (pDC), and mature and regulatory DCs (mregDC). The notable subsets of monocytes and macrophages include classical and non-classical monocytes, macrophages, which demonstrate a continuum from a pro-inflammatory (M1) phenotype to an anti-inflammatory (M2) phenotype, and tumor-associated macrophages (TAMs). Despite their classification in the same cell type, each subset may take on an immune-activating or immunosuppressive phenotype, shaped by factors in the tumor microenvironment (TME). In this review, we introduce the role of DCs, monocytes, and macrophages and recent studies investigating them in the cancer immunity context. Additionally, we review how certain characteristics such as abundance, surface markers, and indirect or direct signaling pathways of DCs and macrophages may influence tumor response to immune checkpoint blockade (ICB) therapy. We also highlight existing knowledge gaps regarding the precise contributions of different myeloid cell subsets in influencing the response to ICB therapy. These findings provide a summary of our current understanding of myeloid cells in mediating cancer immunity and ICB and offer insight into alternative or combination therapies that may enhance the success of ICB in cancers.

An Overview of B-1 Cells as Antigen-Presenting Cells

Role of B cells as antigen presenting cells

The role of B lymphocytes as antigen-presenting cells

New insights into B cells as antigen presenting cells

Early BCR Events and Antigen Capture, Processing, and Loading on MHC Class II on B Cells

Advances in the research of B1-cell and its relationship with diseases

The immunology of B-1 cells: from development to aging

Evolutionary implication of B-1 lineage cells from innate to adaptive immunity

B-1 Cell Heterogeneity and the Regulation of Natural and Antigen-Induced IgM Production

Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis

B Cells in Primitive Vertebrate Act As Pivotal Antigen Presenting Cells in Priming Adaptive Immunity (P5035)

Basophils control T cell priming through soluble mediators rather than antigen presentation

Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade

CD1 molecules: Beyond antigen presentation

Both sides now: evolutionary traits of antigens and B cells in tolerance and activation

Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses

A continuum of CD4+ T cell “help” defines Memory B cell fate

Revisiting the Antigen-Presenting Function of β Cells in T1D Pathogenesis

Implications in Antigen Presentation and T Lymphocyte Activation

B cells: The many facets of B cells in allergic diseases

The Interplay Between Innate-Like B Cells and Other Cell Types in Autoimmunity